356 related articles for article (PubMed ID: 10360673)
21. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
[TBL] [Abstract][Full Text] [Related]
22. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
24. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
25. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity.
Mavros A; Hahn M; Wieland I; Koy S; Koufaki ON; Strelocke K; Koch R; Haroske G; Schackert HK; Eckelt U
J Oral Pathol Med; 2002 May; 31(5):270-6. PubMed ID: 12110043
[TBL] [Abstract][Full Text] [Related]
26. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.
van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC
Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858
[TBL] [Abstract][Full Text] [Related]
27. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
Tsao H; Zhang X; Benoit E; Haluska FG
Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
[TBL] [Abstract][Full Text] [Related]
28. Analysis of PTEN/MMAC1 alteration in neuroblastoma.
Moritake H; Horii Y; Kuroda H; Sugimoto T
Cancer Genet Cytogenet; 2001 Mar; 125(2):151-5. PubMed ID: 11369059
[TBL] [Abstract][Full Text] [Related]
29. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
31. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
32. PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate.
Dong JT; Sipe TW; Hyytinen ER; Li CL; Heise C; McClintock DE; Grant CD; Chung LW; Frierson HF
Oncogene; 1998 Oct; 17(15):1979-82. PubMed ID: 9788441
[TBL] [Abstract][Full Text] [Related]
33. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas.
Kurose K; Zhou XP; Araki T; Eng C
Genes Chromosomes Cancer; 2000 Oct; 29(2):166-72. PubMed ID: 10959096
[TBL] [Abstract][Full Text] [Related]
34. Mutation analysis of PTEN/MMAC1 in acute myeloid leukemia.
Liu TC; Lin PM; Chang JG; Lee JP; Chen TP; Lin SF
Am J Hematol; 2000 Apr; 63(4):170-5. PubMed ID: 10706759
[TBL] [Abstract][Full Text] [Related]
35. PTEN gene alterations in lymphoid neoplasms.
Sakai A; Thieblemont C; Wellmann A; Jaffe ES; Raffeld M
Blood; 1998 Nov; 92(9):3410-5. PubMed ID: 9787181
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
[TBL] [Abstract][Full Text] [Related]
37. [Research on the mechanisms of PTEN gene inactivation in ovarian cancer].
Lü QJ; Zhao XD; Song JY; Li XH; Ma Y; Meng H; Jiang WG
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):266-9. PubMed ID: 16181546
[TBL] [Abstract][Full Text] [Related]
38. Frequent allelic loss at 10q23 but low incidence of PTEN mutations in Merkel cell carcinoma.
Van Gele M; Leonard JH; Van Roy N; Cook AL; De Paepe A; Speleman F
Int J Cancer; 2001 May; 92(3):409-13. PubMed ID: 11291079
[TBL] [Abstract][Full Text] [Related]
39. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
[TBL] [Abstract][Full Text] [Related]
40. The PTEN tumour suppressor gene and malignant melanoma.
Böni R; Vortmeyer AO; Burg G; Hofbauer G; Zhuang Z
Melanoma Res; 1998 Aug; 8(4):300-2. PubMed ID: 9764804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
